Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Genmab A (GMAB) Cash & Equivalents: 2018-2020

Historic Cash & Equivalents for Genmab A (GMAB) over the last 3 years, with Dec 2020 value amounting to $828.6 million.

  • Genmab A's Cash & Equivalents rose 3.35% to $1,034 in Q2 2023 from the same period last year, while for Jun 2023 it was $1,034, marking a year-over-year increase of 3.35%. This contributed to the annual value of $828.6 million for FY2020, which is 165.34% up from last year.
  • Genmab A's Cash & Equivalents amounted to $828.6 million in FY2020, which was up 165.34% from $312.3 million recorded in FY2019.
  • In the past 5 years, Genmab A's Cash & Equivalents registered a high of $828.6 million during FY2020, and its lowest value of $58.9 million during FY2018.
  • Over the past 3 years, Genmab A's median Cash & Equivalents value was $312.3 million (recorded in 2019), while the average stood at $400.0 million.
  • Data for Genmab A's Cash & Equivalents shows a peak YoY soared of 430.04% (in 2019) over the last 5 years.
  • Genmab A's Cash & Equivalents (Yearly) stood at $58.9 million in 2018, then skyrocketed by 430.04% to $312.3 million in 2019, then spiked by 165.34% to $828.6 million in 2020.